Company Overview and News

 
Defexpo 2018: Kalyani Group showcases Bharat 52 towed gun

2018-04-19 janes
India’s Kalyani Group is highlighting its Bharat 52 155 mm/52 calibre towed gun at the Defexpo 2018 exhibition being held in Chennai.
Upvote Downvote

 
PM Modi arrives in Sweden: A look at India#39;s ties with the Nordic country

2018-04-17 moneycontrol
In a first bi-lateral visit by an Indian premier to a Nordic nation in 30 years, Prime Minister Narendra Modi on Tuesday arrived in Stockholm, where he was received by his Swedish counterpart Stefan Lofven.
Upvote Downvote

 
Closing Bell: Nifty rises for 6th straight day, Sensex up 161 pts ahead of macro data

2018-04-12 moneycontrol
3:30 pm Market Closing: Benchmark indices ended higher for the sixth consecutive session, with the Sensex rising 160.69 points to 34,101.13 and the Nifty gaining 41.50 points at 10,458.70 ahead of macro data due later in the day and Infosys earnings tomorrow.
Upvote Downvote

 
Bharat Forge Limited - Press Release

2018-04-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Bharat Forge rises 2%; Nomura neutral on stock with target Rs 741

2018-04-05 moneycontrol
The research house Nomura has kept neutral rating on Bharat Forge with a target of Rs 741 per share.
Upvote Downvote

 
Closing Bell: Sensex falls 352 pts, Nifty Bank loses 381 pts on US-China trade war woes

2018-04-04 moneycontrol
3:30 pm Market Closing: Benchmark indices closed sharply lower after gains seen in previous two consecutive sessions, weighed by US-China trade war concerns.
Upvote Downvote

 
Market Live: Sensex falls 300 pts, Nifty breaks 10,200 on US-China trade war woes; Europe down

2018-04-04 moneycontrol
2:45 pm Market Update: The market is trading near day's low, with the Sensex falling nearly 400 points after China has announced new tariffs on 106 US products, which include soybeans, cars and whisky.
Upvote Downvote

 
Market Live: Sensex falls 250 pts, Nifty breaks 10,200 on US-China trade war woes; Europe down

2018-04-04 moneycontrol
2:00 pm Market Update: Benchmark indices extended losses, with the Sensex falling 333.36 points or 1 percent to 33,037.27 after China unveiled new retaliation plan for US tariffs.
Upvote Downvote

 
Market Live: Sensex, Midcap indices off day#39;s highs; Tata Motors lifts Auto index

2018-04-04 moneycontrol
12:45 pm Market Update: The market continued to be rangebound, with the Nifty hovering around 10,250 levels.
Upvote Downvote

 
Market Live: Midcaps outperform Nifty; ICICI Securities falls sharply on debut

2018-04-04 moneycontrol
10:50 am Order Win: NBCC has received sanction from Ministry of Home Affairs (MHA), Government of India, for the construction of 14,460 bunkers in villages along the Indo-Pak Border in Jammu and Kashmir amounting Rs 415.73 crore.
Upvote Downvote

 
Market Live: Nifty hovers around 10,250, midcaps outshine; Tata Motors extends gains

2018-04-04 moneycontrol
9:50 am Pre-Opening for ICICI Securities, Mishra Dhatu Nigam: ICICI Securities share price settled at Rs 435 in pre-opening trade on the NSE, down 16 percent from issue price of Rs 520.
Upvote Downvote

 
Godrej Aerospace bags ₹200 crore Rolls-Royce deal

2018-03-21 thehindubusinessline
Expanding its partnership with aerospace major Rolls-Royce, Godrej Aerospace, a business unit of Godrej & Boyce, has bagged a ₹200-crore contract. The Indian group will invest ₹50 crore in a new facility, called the Centre of Excellence, with an aim to strengthen its foothold in the aerospace sector.
Upvote Downvote

 
Bharat Forge Limited - Outcome of Board Meeting

2018-03-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Upbeat on growth for all biz verticals; capacity expansion likely: Bharat Forge

2018-03-15 moneycontrol
Baba Kalyani Chairman and Managing Director of Bharat Forge said all their business verticals were growing well and saw huge opportunities in defence and oil and gas business. For the oil and gas biz they supply high-end technology products.
Upvote Downvote

 
Can Liberty House bring back Amtek Auto’s lost glory as a global component supplier?

2018-03-12 livemint
Last Thursday, Amtek Auto Ltd became the first among the 12 large insolvency cases referred to the National Company Law Tribunal to get finalized, as the UK-based industrial conglomerate Liberty House emerged as the preferred bidder to acquire the debt-laden auto components firm.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...